PMID: 6862582Jul 1, 1983Paper

Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension

M G Myers, J de Champlain


The antihypertensive effects of atenolol and hydrochlorothiazide were compared with placebo in a randomized, double-blind crossover study, with the blood pressure responses related to sympathetic nervous system activity. Twelve patients with essential hypertension were given atenolol (100 mg), hydrochlorothiazide (50 mg), and placebo as single daily doses, each for 6 weeks. Mean supine, standing, and post-exercise blood pressures (mm Hg) on atenolol (155/94, 152/95, 177/93, respectively) and hydrochlorothiazide (154/99, 150/103, 172/96) were lower (p less than 0.01) than corresponding placebo values (172/109, 166/113, 204/111) at 6 weeks. The role of the sympathetic nervous system in the antihypertensive actions of atenolol and hydrochlorothiazide was examined. The supine plasma norepinephrine on placebo was used as an index of sympathetic activity to categorize each patient's "adrenergic status." The six "hyperadrenergic" patients with high resting norepinephrine values (mean, 302 pg/ml) exhibited a greater (p = 0.05) decrease in BP (-30/-20 mm Hg) on atenolol compared with the BP fall of -9/-11 mm Hg observed in the lower norepinephrine group (mean, 211 pg/ml). Resting plasma norepinephrine values did not predict the BP fall ...Continue Reading


Nov 1, 1976·Clinical Pharmacology and Therapeutics·H C BrownR G Shanks
Jun 1, 1978·European Journal of Clinical Investigation·K H RahnW Stephany
May 17, 1975·British Medical Journal·L HanssonA Westerlund
Apr 1, 1979·British Journal of Clinical Pharmacology·D N BatemanC T Dollery
Apr 1, 1979·Clinical Pharmacology and Therapeutics·W D MasonR M Bell
Sep 1, 1979·Clinical Pharmacology and Therapeutics·N WinerR M Bell
Oct 1, 1979·Clinical Pharmacology and Therapeutics·C R LakeI J Kopin
Apr 24, 1976·British Medical Journal·A P Douglas-Jones, J M Cruickshank
May 1, 1976·Clinical Pharmacology and Therapeutics·M G MyersC T Dollery
Jan 27, 1977·The New England Journal of Medicine·C R LakeI J Kopin
Oct 18, 1975·British Medical Journal·J C PetrieJ A Lewis
Feb 1, 1973·Analytical Biochemistry·P G Passon, J D Peuler
Mar 1, 1980·The Journal of Clinical Investigation·D C Deibert, R A DeFronzo
May 1, 1982·British Journal of Clinical Pharmacology·H H VincentM A Schalekamp
Jan 1, 1982·Clinical Pharmacology and Therapeutics·M J BrownC T Dollery
Feb 1, 1981·Clinical Science·M D EslerP I Korner
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·J de ChamplainG Denis
Sep 1, 1981·British Journal of Clinical Pharmacology·M D EslerG L Jennings
Jan 1, 1980·Clinical and Experimental Hypertension : CHE·J de ChamplainL Lapointe


Jan 1, 1986·European Journal of Clinical Pharmacology·R VandongenP Rogers
Aug 20, 2015·Naunyn-Schmiedeberg's Archives of Pharmacology·Federica SereniPaola Bagnoli
Feb 19, 2016·American Journal of Hypertension·Guido Grassi
Nov 12, 2009·Journal of Cardiovascular Pharmacology and Therapeutics·S P BelokaP van de Borne
Nov 1, 1986·Hypertension·S LandahlK Svärdsudd
May 30, 2014·The Cochrane Database of Systematic Reviews·Vijaya M MusiniJames M Wright
Mar 11, 2016·The Cochrane Database of Systematic Reviews·Gavin W K WongJames M Wright

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.